Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-02 Sale |
2024-05-03 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
467 | $402.95 | $188,178 | 4,435 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-03 4:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
240 | $419 | $100,560 | 7,500 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 5:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
354 | $425.7 | $150,698 | 55,804 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:59 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
3,004 | $425.7 | $1,278,803 | 62,772 (Indirect Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:44 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
883 | $425.7 | $375,893 | 15,972 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:37 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,034 | $425.7 | $2,142,974 | 49,831 (Indirect Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:29 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
883 | $425.7 | $375,893 | 7,965 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,239 | $425.7 | $1,804,542 | 25,813 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:28 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
360 | $421.77 | $151,837 | 59,467 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:20 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
3,191 | $421.77 | $1,345,868 | 68,245 (Indirect Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,201 | $421.77 | $506,546 | 18,509 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,603 | $421.77 | $1,519,637 | 59,579 (Indirect Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,002 | $421.77 | $1,266,154 | 34,022 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:43 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
480 | $420.79 | $201,979 | 59,827 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:38 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
4,254 | $420.79 | $1,790,041 | 71,436 (Indirect Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
801 | $420.79 | $337,053 | 19,710 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,804 | $420.79 | $2,021,475 | 63,182 (Indirect Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,002 | $420.79 | $1,684,002 | 37,024 (Direct) |
View |
| 2024-02-14 Sale |
2024-02-16 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
9,011 | $419.1 | $3,776,528 | 18,336 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
3,393 | $419.42 | $1,423,104 | 27,347 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 5:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
314 | $420.24 | $131,955 | 68,179 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 5:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
3,222 | $420.24 | $1,354,013 | 81,811 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:56 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
1,738 | $418.77 | $727,822 | 18,280 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:54 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
913 | $420.24 | $383,679 | 23,137 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,295 | $420.24 | $1,804,931 | 75,858 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,374 | $420.24 | $577,410 | 9,676 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-01 Option Award |
2024-05-03 4:14 pm |
N/A 2034-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
3,142 | $0 | 3,142 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:11 pm |
N/A 2034-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Garber Alan M Director |
3,142 | $0 | 3,142 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | CARNEY LLOYD Director |
1,001 | $0 | 6,319 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,001 | $0 | 4,435 (Direct) |
View |
| 2024-04-15 Option Award |
2024-04-17 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
109 | $399.58 | 14,854 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 4:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
225 | $418.1 | 7,500 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 5:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,309 | $431.79 | 53,583 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 5:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,309 | $431.79 | 55,804 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:59 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
2,469 | $431.79 | 62,772 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:55 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,386 | $431.79 | 136,507 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
3,309 | $431.79 | 36,939 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,654 | $431.79 | 15,972 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,714 | $431.79 | 49,831 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
828 | $431.79 | 7,965 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,970 | $431.79 | 25,813 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,750 | $424.01 | 56,892 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,812 | $420.58 | 56,892 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,499 | $424.01 | 59,827 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,373 | $420.58 | 59,827 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
3,498 | $424.01 | 71,436 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
2,623 | $420.58 | 71,436 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:34 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
4,118 | $420.58 | 14,218 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,359 | $424.01 | 145,893 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
7,019 | $420.58 | 145,893 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
3,750 | $424.01 | 40,248 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,812 | $420.58 | 40,248 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,501 | $424.01 | 19,710 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,125 | $420.58 | 19,710 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,499 | $424.01 | 63,182 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,373 | $420.58 | 63,182 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,750 | $424.01 | 37,024 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,812 | $420.58 | 37,024 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:34 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,607 | $422.74 | 63,454 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,100 | $422.74 | 68,179 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
2,022 | $422.74 | 81,811 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
8,255 | $422.74 | 162,271 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:01 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,100 | $422.74 | 46,810 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:56 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
1,588 | $422.74 | 18,280 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:54 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
832 | $422.74 | 23,137 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,177 | $422.74 | 75,858 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
591 | $422.74 | 9,676 (Direct) |
View |